Drug Trials Snapshot: LIVMARLI (maralixibat chloride)

Drug Trials Snapshot: LIVMARLI (maralixibat chloride) LIVMARLI is a drug for the treatment of itching (pruritus) due to blockage of bile flow out of the liver (cholestasis) in patients with Alagille syndrome (ALGS) one year of age and older. ALGS is an inherited disorder than can affect the liver and other parts of the body. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshot-livmarli